CRVS · Corvus Pharmaceuticals, Inc. · Documents
$10.53
-0.12 (-1.13%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$885.79M
Shares
84.12M
Volume · Oct 23
933.82K
Avg daily vol (3M)
991.43K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-07-07 | — | |
| 8-K | — | 2020-06-10 | 2020-06-09 | |
| 8-K | — | 2020-05-29 | — | |
| 10-Q | — | 2020-04-30 | 2020-03-31 | |
| 8-K | — | 2020-04-30 | — | |
| DEF 14A | — | 2020-04-15 | 2020-06-09 | |
| 8-K | — | 2020-03-20 | 2020-03-19 | |
| 10-K | — | 2020-03-09 | 2019-12-31 | |
| 8-K | — | 2020-03-05 | — | |
| 8-K | — | 2020-02-13 | — | |
| 8-K | — | 2020-02-03 | 2020-02-01 |
Showing 101–111 of 111 filings
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
16 filings
16 filers
Visit website
Investor relations